Compare GSK plc (GSK) vs State Street Real Estate Select Sector SPDR ETF (XLRE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs State Street Real Estate Select Sector SPDR ETF — how do they compare? GSK plc trades at $50.45 (market cap $101.13B), while State Street Real Estate Select Sector SPDR ETF trades at $45.16. The key difference: GSK plc pays a 3.61% dividend while State Street Real Estate Select Sector SPDR ETF pays none, and State Street Real Estate Select Sector SPDR ETF is trading nearer its 52-week high, GSK plc nearer its low. Which is the better fit depends on your goals.
| GSK | XLRE | |
|---|---|---|
Market Cap | $101.13B | — |
Sector | Health | Sector/Thematic |
52-Week High | $61.18 | $46.01 |
52-Week Low | $38.96 | $40.01 |
Enterprise Value | $121.57B | — |
Dividend Yield | 3.61% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About State Street Real Estate Select Sector SPDR ETF
XLRE tracks the Real Estate Select Sector Index, providing exposure to S&P 500 real estate companies. It focuses on equity REITs across residential, industrial, and healthcare sub-sectors, with top holdings like Welltower, Prologis, and American Tower.
Read more on XLRE →
